Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in REVB held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 323K | $388K | -25.6% | 10.077% | 0.01% |
| 2 | SABBY MANAGEMENT, LLC | 99K | $119K | -83.6% | 3.100% | 2.09% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 43K | $52K | +27.0% | 1.347% | 0.00% |
| 4 | VANGUARD FIDUCIARY TRUST CO | 13K | $16K | — | 0.409% | 0.00% |
| 5 | XTX Topco Ltd | 11K | $14K | +0.6% | 0.355% | 0.00% |
| 6 | UBS Group AG | 4K | $5K | +468.4% | 0.128% | 0.00% |
| 7 | Tower Research Capital LLC (TRC) | 4K | $5K | — | 0.127% | 0.00% |
| 8 | ROYAL BANK OF CANADA | 747 | $1K | +37250.0% | 0.023% | 0.00% |
| 9 | SBI Securities Co., Ltd. | 344 | $413 | -24.9% | 0.011% | 0.00% |
| 10 | HARBOUR INVESTMENTS, INC. | 41 | $49 | — | 0.001% | 0.00% |
| 11 | BNP Paribas Asset Management Holding S.A. | 9 | $11 | -76.3% | 0.000% | 0.00% |
| 12 | Caitong International Asset Management Co., Ltd | 1 | $1 | — | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in REVB — a direct measure of their conviction.
Filings activity in REVB during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new REVB position in Q1 2026
Institutions that fully closed their REVB position in Q1 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 12 | 14% | 18.77% | 11.65 pp | $1M | 38% |
| Q4 2025 | 14 | +56% | 30.42% | +16.96 pp | $1M | +126% |
| Q3 2025 | 9 | +13% | 13.46% | +11.45 pp | $0M | +570% |
| Q2 2025 | 8 | +14% | 2.01% | +1.62 pp | $0M | +419% |
| Q1 2025 | 7 | +250% | 0.39% | +0.39 pp | $0M | +8805% |
| Q4 2024 | 2 | +100% | 0.00% | +0.00 pp | $0M | — |
| Q3 2024 | 1 | +0.0% | 0.00% | +0.00 pp | $0M | — |
| Q2 2024 | 1 | — | 0.00% | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying REVB stock.
Based on Q1 2026 13F filings, institutional ownership of Revelation Biosciences, Inc. stands at 18.8%, held across 12 reporting institutions.
ARMISTICE CAPITAL, LLC is the largest reported institutional holder of REVB, with approximately 323,241 shares worth $0.00B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of REVB.
Our composite Smart Money Score for REVB is 20 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
4 institutions opened new positions in REVB during Q1 2026, while 6 fully exited. 5 added to existing positions and 1 trimmed.
REVB institutional ownership fell by 11.65 percentage points quarter-over-quarter, with a net change of -2 holders.
The top 10 institutions account for 100.0% of all reported 13F value in REVB, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Revelation Biosciences, Inc. (REVB) Institutional Ownership